Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation

American Journal of Transplantation

Volumn 15, Issue 5, 2015, Pages 1421-1431

  Diaz Siso, J R ^a   Fischer, S ^a,b   Sisk, G C ^a   Bueno, E ^a   Kueckelhaus, M ^a   Talbot, S ^a   Carty, M J ^a   Treister, N S ^a   Marty, F ^a   Milford, E L ^a   Pomahac, B ^a   Tullius, S G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

clinical research practice; drug toxicity; immunosuppressant; steroid; vascularized composite and reconstructive transplantation

Indexed keywords

DEXAMETHASONE; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLATE MOFETIL;

ACUTE GRAFT REJECTION; ADULT; AGED; ALLOGRAFT; ALLOTRANSPLANTATION; ARM AMPUTATION; ARTICLE; BELOW KNEE AMPUTATION; CLINICAL ARTICLE; FACE ERYTHEMA; FACIAL TRANSPLANTATION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAINTENANCE THERAPY; MALE; MIDDLE AGED; PRIORITY JOURNAL; ROSACEA; SCREENING; SEPSIS; SEPTIC SHOCK; SWELLING; THRUSH; TREATMENT DURATION; TREATMENT RESPONSE; UROLITHIASIS; VASCULAR COMPOSITE TISSUE ALLOTRANSPLANTATION; ANALOGS AND DERIVATIVES; BLOOD VESSEL GRAFT; CASE REPORT; GRAFT REJECTION; HAND TRANSPLANTATION; PROCEDURES; TIME; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

ADULT; AGED; ANTILYMPHOCYTE SERUM; FACIAL TRANSPLANTATION; FEMALE; GRAFT REJECTION; HAND TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; STEROIDS; TACROLIMUS; TIME FACTORS; VASCULAR GRAFTING; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

EID: 84928076753     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13103     Document Type: Article

References (59)

1. Marchioro TL, Axtell HK, Lavia MF, Waddell WR, Starzl TE.; The role of adrenocortical steroids in reversing established homograft rejection. Surgery 1964; 55: 412-417.
2. Woodle ES, prospective A.; randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: One year report. Transplant Proc 2005; 37: 804-808.
3. Miller LW.; Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807-818.
4. Rike AH, Mogilishetty G, Alloway RR, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008; 22: 229-235.
5. Sinclair NR.; Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. CMAJ 1992; 147: 645-657.
6. Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H.; Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 1352-1359.
7. Grewal HP, Thistlethwaite JR Jr, Loss GE, et al. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc 1998; 30: 1378-1379.
8. Hanaway MJ, Roy-Chaudhury P, Buell JF, et al. Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc 2005; 37: 1287-1288.
9. Kaufman DB, Leventhal JR, Koffron AJ, et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: Comparison of two maintenance immunosuppression protocols: Tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002; 73: 169-177.
10. Rogers CC, Alloway RR, Boardman R, et al. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplan Proc 2005; 37: 812-813.
11. Rogers CC, Alloway RR, Buell JF, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation 2005; 80: 26-33.
12. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P.; A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248: 564-577.
13. Augustine JJ, Hricik DE.; Are maintenance corticosteroids no longer necessary after kidney transplantation ? Clin J Am Soc Nephrol 2012; 7: 383-384.
14. Hricik DE, Augustine JJ, Knauss TC, et al. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2007; 83: 277-281.
15. Hricik DE, Knauss TC, Bodziak KA, et al. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2003; 76: 938-942.
16. Opelz G, Dohler B.; Association between steroid dosage and death with a functioning graft after kidney transplantation. Am J Transplant 2013; 13: 2096-2105.
17. Castel MA, Vallejos I, Ramos P, et al. Outcome after steroid withdrawal in heart transplantation. Transplant Proc 2009; 41: 2253-2255.
18. Faulhaber M, Mading I, Malehsa D, Raggi MC, Haverich A, Bara CL.; Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantation. Int Immunopharmacol 2013; 15: 712-717.
19. Ramirez CB, Doria C, Frank AM, Armenti ST, Marino IR.; Completely steroid-free immunosuppression in liver transplantation: A randomized study. Clin Transplant 2013; 27: 463-471.
20. Knight SR, Morris PJ.; Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010; 89: 1-14.
21. Knight SR, Morris PJ.; Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis. Transpl Int 2011; 24: 1198-1207.
22. Ahsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68: 1865-1874.
23. Pascual J, Zamora J, Galeano C, Royuela A, Quereda C.; Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009; 1: CD005632.
24. Khalifian S, Brazio PS, Mohan R, et al. Facial transplantation: The first 9 years. Lancet 2014.
25. Sarhane KA, Tuffaha SH, Broyles JM, et al. A critical analysis of rejection in vascularized composite allotransplantation: Clinical, cellular and molecular aspects, current challenges, and novel concepts. Front Immunol 2013; 4: 406.
26. Pomahac B, Pribaz J, Eriksson E, et al. Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant 2011; 11: 386-393.
27. Pomahac B, Lengele B, Ridgway EB, et al. Vascular considerations in composite midfacial allotransplantation. Plast Reconstr Surg 2010; 125: 517-522.
28. Diaz-Siso JR, Parker M, Bueno EM, et al. Facial allotransplantation: a 3-year follow-up report. J Plast Reconstr Aesthet Surg 2013; 66: 1458-1463.
29. Pomahac B, Pribaz J, Eriksson E, et al. Three patients with full facial transplantation. N Engl J Med 2012; 366: 715-722.
30. Pomahac B, Pribaz JJ, Bueno EM, et al. Novel surgical technique for full face transplantation. Plast Reconstr Surg 2012; 130: 549-555.
31. Kueckelhaus M, Fischer S, Lian CG, et al. Utility of sentinel flaps in assessing facial allograft rejection. Plast Reconstr Surg 2014.
32. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008; 372: 631-638.
33. Siemionow M, Ozturk C.; An update on facial transplantation cases performed between 2005 and 2010. Plast Reconstr Surg 2011; 128: 707e-720e.
34. Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant 2012; 12: 1004-1016.
35. Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg 2013; 257: 345-351.
36. Dorafshar AH, Bojovic B, Christy MR, et al. Total face, double jaw, and tongue transplantation: An evolutionary concept. Plast Reconstr Surg 2013; 131: 241-251.
37. Barret JP, Gavalda J, Bueno J, et al. Full face transplant: The first case report. Ann Surg 2011; 254: 252-256.
38. Brandacher G, Ninkovic M, Piza-Katzer H, et al. The Innsbruck hand transplant program: Update at 8 years after the first transplant. Transplant Proc 2009; 41: 491-494.
39. Petruzzo P, Kanitakis J, Badet L, et al. Long-term follow-up in composite tissue allotransplantation: In-depth study of five (hand and face) recipients. Am J Transplant 2011; 11: 808-816.
40. Lantieri L, Hivelin M, Audard V, et al. Feasibility, reproducibility, risks and benefits of face transplantation: A prospective study of outcomes. Am J Transplant 2011; 11: 367-378.
41. Bueno EM, Diaz-Siso JR, Pomahac B.; A multidisciplinary protocol for face transplantation at Brigham and Women's Hospital. J Plast Reconstr Aesthet Surg 2011; 64: 1572-1579.
42. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008; 8: 1396-1400.
43. Lian CG, Bueno EM, Granter SR, et al. Biomarker evaluation of face transplant rejection: Association of donor T cells with target cell injury. Mod Pathol 2014; 27: 788-799.
44. Saavedra AP, Bueno EM, Granter SR, Pomahac B.; Transmission of donor-specific skin condition from donor to recipient of facial allograft. Am J Transplant 2011; 11: 1340.
45. Knoll BM, Hammond SP, Koo S, et al. Infections following facial composite tissue allotransplantation-single center experience and review of the literature. Am J Transplant 2013; 13: 770-7779.
46. Hautz T, Brandacher G, Zelger B, et al. Immunologic aspects and rejection in solid organ versus reconstructive transplantation. Transplant Proc 2010; 42: 3347-3353.
47. Breidenbach WC, Gonzales NR, Kaufman CL, Klapheke M, Tobin GR, Gorantla VS.; Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant. J Hand Surg 2008; 33: 1039-1047.
48. Petruzzo P, Testelin S, Kanitakis J, et al. First human face transplantation: 5 years outcomes. Transplantation 2012; 93: 236-240.
49. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet 2003; 361: 2173-2176.
50. Cipriani R, Contedini F, Santoli M, et al. Abdominal wall transplantation with microsurgical technique. Am J Transplant 2007; 7: 1304-1307.
51. Cavadas PC, Ibanez J, Thione A, Alfaro L.; Bilateral trans-humeral arm transplantation: Result at 2 years. Am J Transplant 2011; 11: 1085-1090.
52. Kaufman CL, Breidenbach W.; World experience after more than a decade of clinical hand transplantation: Update from the Louisville hand transplant program. Hand Clin 2011; 27: 417-421, vii-viii.
53. Diaz-Siso JR, Bueno EM, Sisk GC, Marty FM, Pomahac B, Tullius SG.; Vascularized composite tissue allotransplantation-state of the art. Clin Transplant 2013; 27: 330-337.
54. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2010; 90: 1590-1594.
55. Ciancio G, Burke GW, Gaynor JJ, et al. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation 2005; 80: 457-465.
56. Unadkat JV, Schneeberger S, Horibe EH, et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant 2010; 10: 251-261.
57. Lanzetta M, Petruzzo P, Margreiter R, et al. The international registry on hand and composite tissue transplantation. Transplantation 2005; 79: 1210-1214.
58. Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation 2008; 86: 487-492.
59. Francois CG, Breidenbach WC, Maldonado C, et al. Hand transplantation: Comparisons and observations of the first four clinical cases. Microsurgery 2000; 20: 360-371.